A single-arm confirmatory trial of pazopanib in patients with paclitaxel-pretreated primary cutaneous angiosarcoma: Japan Clinical Oncology Group study (JCOG1605, JCOG-PCAS protocol).

Oashi, Kohei; Shibata, Taro; Namikawa, Kenjiro; Takahashi, Akira; Yokota, Kenji; Nakano, Eiji; Teramoto, Yukiko; Tsutsumida, Arata; Maeda, Taku; Yamazaki, Naoya

Oashi, Kohei; Shibata, Taro; Namikawa, Kenjiro; Takahashi, Akira; Yokota, Kenji; Nakano, Eiji; Teramoto, Yukiko; Tsutsumida, Arata; Maeda, Taku; Yamazaki, Naoya.

Afiliação

Oashi K; Department of Dermatology, Saitama Cancer Center, 780 Komuro, Ina, Kita-adachi-gun, Saitama, 362-0806, Japan. oashi@cancer-c.pref.saitama.jp.
Shibata T; JCOG Data Center/Operations Office, National Cancer Center Hospital, Tokyo, Japan.
Namikawa K; Department of Dermatologic Oncology, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.
Takahashi A; Department of Dermatologic Oncology, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.
Yokota K; Department of Dermatology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
Nakano E; Department of Dermatologic Oncology, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.
Teramoto Y; Department of Skin Oncology/Dermatology, Saitama Medical University International Medical Center, Saitama, Japan.
Tsutsumida A; Department of Dermatologic Oncology, Dermatology, Cancer Institute Hospital, Tokyo, Japan.
Maeda T; Department of Plastic and Reconstructive Surgery, Faculty of Medicine and Graduate School of Medicine Hokkaido University, Sapporo, Japan.
Yamazaki N; Department of Dermatologic Oncology, National Cancer Center Hospital, 5-1-1 Tsukiji, Chuo-ku, Tokyo, 104-0045, Japan.

BMC Cancer ; 20(1): 652, 2020 Jul 13.

Article em En | MEDLINE | ID: mdl-32660439

Assuntos

Antineoplásicos Fitogênicos/uso terapêutico; Resistencia a Medicamentos Antineoplásicos/efeitos dos fármacos; Hemangiossarcoma/tratamento farmacológico; Paclitaxel/farmacologia; Pirimidinas/uso terapêutico; Terapia de Salvação; Neoplasias Cutâneas/tratamento farmacológico; Sulfonamidas/uso terapêutico; Adulto; Idoso; Idoso de 80 Anos ou mais; Feminino; Seguimentos; Hemangiossarcoma/patologia; Humanos; Indazóis; Masculino; Pessoa de Meia-Idade; Prognóstico; Projetos de Pesquisa; Neoplasias Cutâneas/patologia; Adulto Jovem

Palavras-chave

Angiosarcoma; Chemotherapy; Paclitaxel-resistant; Pazopanib; Single arm comfirmatory trial

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Pirimidinas / Neoplasias Cutâneas / Sulfonamidas / Terapia de Salvação / Paclitaxel / Resistencia a Medicamentos Antineoplásicos / Hemangiossarcoma / Antineoplásicos Fitogênicos Tipo de estudo: Clinical_trials / Guideline / Observational_studies / Prognostic_studies / Risk_factors_studies / Systematic_reviews Limite: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google